About IPSEN

About Ipsen Pty Ltd

  • Ipsen Pty Ltd has been in operation since 2001. It is the Australian affiliate of a global specialty driven company with total sales exceeding €1.225 billion in 2014.
  • Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases.
  • Its development strategy is supported by franchises: neurology / Dysport®, oncology-endocrinology / Somatuline®, uro-oncology / Diphereline®.
  • Moreover, the Group has an active policy of partnerships.
  • R&D is focused on innovative and differentiated technological patient driven platforms, peptides and toxins.
  • In 2014, R&D expenditure totaled more than €187 million (15% of Group sales).
  • The group has total worldwide staff of more than 4500.

 

Ipsen - Brand Video Master from Ipsen Pty Ltd on Vimeo.


 

3 Targeted Specialty Care Areas

Ipsen focuses its resources and investments on three targeted specialty care areas, organized in Franchises. In these areas, Ipsen operates throughout the entire value chain, from research through to marketing.

 

Join Ipsen Pty Ltd

Please see the offers and send your application via LinkedIn Or E-mail: grouprecruitment@ipsen.com